PTGX · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2023-11-02 compared with 2023-08-03 · 3 added, 2 removed, 27 unchanged (16% of the section changed)
5 unchanged sentences
Amended and Restated Bylaws
+Added: Form of Pre-Funded Warrant
Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
14 unchanged sentences
PROTAGONIST THERAPEUTICS, INC.
−Removed: August 3, 2023
+Added: November 2, 2023
/s/ Dinesh V.
1 unchanged sentence
(Principal Executive Officer)
−Removed: August 3, 2023
+Added: November 2, 2023
Executive Vice President, Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.